MPS Pharmaa Ltd Approves Retrenchment of 10 Workers Amid Diversification Into Natural Healthcare

MPS Pharmaa Ltd has announced a permanent retrenchment of 10 workers at its Haryana plant, effective April 2, 2026. The decision was approved by the company’s Board as part of a strategic business diversification plan into natural healthcare segments, including Ayurvedic, Unani, and Homeopathic medicines.

The retrenchment, carried out in compliance with the Industrial Relations Code, 2020, reflects the company’s intent to optimize costs and restructure its workforce to meet the specialized requirements of natural healthcare production. While the move impacts a small portion of the workforce, analysts note it signals a broader shift in MPS Pharmaa’s operational priorities.

Industry experts suggest that the company’s pivot toward natural healthcare aligns with rising consumer demand for holistic wellness solutions, potentially opening new growth avenues. However, the retrenchment underscores the challenges of balancing workforce stability with evolving business strategies.

Key Highlights

• Decision: Retrenchment of 10 workers approved.
• Effective Date: April 2, 2026.
• Location: Haryana manufacturing facility.
• Reason: Diversification into Ayurvedic, Unani, and Homeopathic medicines.
• Compliance: Conducted under Industrial Relations Code, 2020.
• Strategic Goal: Cost optimization and specialized workforce restructuring.

Sources: ScanX News, The Economic Times, MarketScreener